Skip to main content

Table 3 Hazard ratio per SD increase in marker value stratified into death cause and adjusted for physical/metabolic markers, EU SCORE, and Framingham score respectively.

From: Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women

Adjusted by

HR/SD -

HR/SD Physical/metabolic

HR/SD EU SCORE

HR/SD Framingham

AC24

    

CVD

1.66 (1.25-2.19)***

NS

1.38 (1.02-1.86)*

NS

CVD/cancer

1.64 (1.35-2.00)***

1.31 (1.06-1.63)*

1.40 (1.13-1.72)**

1.29 (1.02-1.63)*

Area

    

CVD

1.60 (1.16-2.20)**

NS

NS

NS

CVD/cancer

1.68 (1.36-2.09)***

1.32 (1.04-1.66)*

1.47 (1.16-1.86)**

1.34 (1.04-1.72)*

Sim. Area

    

CVD

2.96 (1.76-4.99)***

2.00 (1.15-3.49)*

2.46 (1.41-4.27)**

2.27 (1.26-4.09)**

CVD/cancer

2.37 (1.73-3.25)***

1.68 (1.20-2.34)**

1.96 (1.40-2.73)***

1.79 (1.26-2.54)**

Thickness%

    

CVD

NS

NS

NS

NS

CVD/cancer

1.45(1.20-1.75)***

NS

1.27 (1.04-1.55)*

NS

Wall %

    

CVD

1.50 (1.16-1.95)**

NS

NS

NS

CVD/cancer

1.60 (1.34-1.91)***

1.26 (1.04-1.53)*

1.42 (1.17-1.73)***

1.30 (1.05-1.62)*

Length%

    

CVD

1.55 (1.18-2.04)**

NS

NS

NS

CVD/cancer

1.61 (1.34-1.95)***

1.26 (1.03-1.55)*

1.42 (1.16-1.73)***

1.29 (1.03-1.62)*

NCD

    

CVD

2.44 (1.72-3.48)***

1.76 (1.20-2.60)**

2.20 (1.48-3.26)***

2.04 (1.34-3.12)***

CVD/cancer

2.28(1.79-2.90)***

1.69 (1.30-2.21)***

2.00 (1.53-2.62)***

1.86 (1.40-2.47)***

MAD factor

    

CVD

3.37 (1.83-6.21)***

2.44 (1.22-4.89)*

3.02 (1.55-5.86)**

2.85 (1.44-5.64)**

CVD/cancer

2.19 (1.58-3.04)***

1.58 (1.11-2.26)*

1.83 (1.29-2.59)***

1.74 (1.22-2.48)**

MACD index

    

CVD

5.22 (2.40-11.36)***

3.17 (1.48-6.78)**

4.36 (1.97-9.66)***

4.22 (1.79-9.97)***

CVD/cancer

2.99 (2.05-4.35)***

2.01 (1.37-2.95)***

2.43 (1.64-3.59)***

2.27 (1.51-3.41)***

  1. (* p < 0.05, ** p < 0.01, *** p < 0.001)